Immune-mediated destruction of transfected muscle fibers after direct gene transfer with antigen-expressing plasmid DNA - PubMed (original) (raw)
Immune-mediated destruction of transfected muscle fibers after direct gene transfer with antigen-expressing plasmid DNA
H L Davis et al. Gene Ther. 1997 Mar.
Abstract
DNA-based immunization of mice by intramuscular injection of antigen-encoding plasmid DNA results in immune responses which may be sustained for extended periods of time without an antigen boost. For example, we have previously shown that a strong humoral response against hepatitis B virus surface antigen (HBsAg) will persist for up to 74 weeks following a single intramuscular administration of DNA. It has been proposed that the longevity of the response is due to sustained expression of antigen in transfected muscle cells. However, here we show by immunohistochemistry and electron microscopy that HBsAg-expressing muscle fibers are destroyed around 10 days after injection of DNA in mice. We have also evaluated destruction of the transfected muscle fibers indirectly, by measurement of luciferase activity in muscles at different times after injection of a luciferase reporter gene construct, alone or in combination with HBsAg-expressing DNA. Control muscles injected with luciferase-expressing DNA alone maintain expression of high levels of luciferase for at least 60 days. In contrast, muscles co-injected with DNAs expressing luciferase and a secreted form of HBsAg show high levels of luciferase activity at 5 days but > 99% of this is lost by 20 days. Similar results are obtained with co-expression of luciferase and beta-galactosidase, a non-secreted antigen. Loss of luciferase expression does not occur in muscles of mice with severe combined immunodeficiency, indicating that the myofiber destruction is immunologically mediated.
Similar articles
- Cationic polymers that enhance the performance of HbsAg DNA in vivo.
Bos GW, Kanellos T, Crommelin DJ, Hennink WE, Howard CR. Bos GW, et al. Vaccine. 2004 Dec 9;23(4):460-9. doi: 10.1016/j.vaccine.2004.06.020. Vaccine. 2004. PMID: 15530694 - Cationic transfersomes based topical genetic vaccine against hepatitis B.
Mahor S, Rawat A, Dubey PK, Gupta PN, Khatri K, Goyal AK, Vyas SP. Mahor S, et al. Int J Pharm. 2007 Aug 1;340(1-2):13-9. doi: 10.1016/j.ijpharm.2007.03.006. Epub 2007 Mar 12. Int J Pharm. 2007. PMID: 17446015 - Pharmacological enhancement of in vivo foreign gene expression in muscle.
Danko I, Fritz JD, Jiao S, Hogan K, Latendresse JS, Wolff JA. Danko I, et al. Gene Ther. 1994 Mar;1(2):114-21. Gene Ther. 1994. PMID: 7584066 - Revealing the potential of DNA-based vaccination: lessons learned from the hepatitis B virus surface antigen.
Schirmbeck R, Reimann J. Schirmbeck R, et al. Biol Chem. 2001 Apr;382(4):543-52. doi: 10.1515/BC.2001.068. Biol Chem. 2001. PMID: 11405219 Review. - Use of plasmid DNA for direct gene transfer and immunization.
Davis HL, Michel ML, Whalen RG. Davis HL, et al. Ann N Y Acad Sci. 1995 Nov 27;772:21-9. doi: 10.1111/j.1749-6632.1995.tb44728.x. Ann N Y Acad Sci. 1995. PMID: 8546395 Review.
Cited by
- Blocking T-cell egress with FTY720 extends DNA vaccine expression but reduces immunogenicity.
Mann JFS, McKay PF, Klein K, Pankrac J, Tregoning JS, Shattock RJ. Mann JFS, et al. Immunology. 2022 Mar;165(3):301-311. doi: 10.1111/imm.13429. Epub 2021 Dec 12. Immunology. 2022. PMID: 34775601 Free PMC article. - Update on treatment and preventive interventions against COVID-19: an overview of potential pharmacological agents and vaccines.
Xiao Y, Xu H, Guo W, Zhao Y, Luo Y, Wang M, He Z, Ding Z, Liu J, Deng L, Sha F, Ma X. Xiao Y, et al. Mol Biomed. 2020;1(1):16. doi: 10.1186/s43556-020-00017-w. Epub 2020 Dec 3. Mol Biomed. 2020. PMID: 34765999 Free PMC article. Review. - Regulatory T Cells Modulate DNA Vaccine Immunogenicity at Early Time via Functional CD4(+) T Cells and Antigen Duration.
Qin L, Jiang G, Han J, Letvin NL. Qin L, et al. Front Immunol. 2015 Sep 29;6:510. doi: 10.3389/fimmu.2015.00510. eCollection 2015. Front Immunol. 2015. PMID: 26483796 Free PMC article. - Strategies and hurdles using DNA vaccines to fish.
Hølvold LB, Myhr AI, Dalmo RA. Hølvold LB, et al. Vet Res. 2014 Feb 19;45(1):21. doi: 10.1186/1297-9716-45-21. Vet Res. 2014. PMID: 24552235 Free PMC article. Review. - A combination of intradermal jet-injection and electroporation overcomes in vivo dose restriction of DNA vaccines.
Hallengärd D, Bråve A, Isaguliants M, Blomberg P, Enger J, Stout R, King A, Wahren B. Hallengärd D, et al. Genet Vaccines Ther. 2012 Aug 8;10(1):5. doi: 10.1186/1479-0556-10-5. Genet Vaccines Ther. 2012. PMID: 22873174 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources